- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Lysosomal Therapeutics Inc.
Headquarters: Cambridge, MA, United States
Website: N/A
Year Founded: 2011
Status: Acquired
BioCentury | Oct 2, 2020
Deals
From Termeer to scuttled Allergan deal, Lysosomal’s winding road continues with Bial takeout
A takeout by Bial brings to an end Lysosomal’s search for a partner to advance its Parkinson’s programs after Allergan turned down its option to acquire the biotech last year.
BioCentury | Nov 8, 2019
Emerging Company Profile
Arkuda emerges from Atlas with genetic dementia program
Atlas-founded Arkuda debuts with genetically-defined frontotemporal dementia therapy, $44M A round
BioCentury | Oct 17, 2019
Preclinical News
Oct. 17 Preclinical Quick Takes: Miromatrix, Mayo extend vascular function in liver graft scaffold; plus James Allison-MD Anderson, Northwestern and Eleusis
BioCentury | Sep 19, 2019
Company News
Management tracks: CASI promotes Zhang to president; plus Five Prime, Black Diamond, Oyster Point, Enyo, X4, Nimbus and Canbridge
BioCentury | Aug 23, 2019
Company News
Management tracks: Erasca, Frequency, PerkinElmer, CytomX, Infinity and more
BioCentury | May 20, 2017
Strategy
Henri: N of 1
How the late Genzyme CEO Henri Termeer created the Orphan drug industry
Items per page:
1 - 10 of 16